NCT01074372View on ClinicalTrials.gov

Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

REGN727

4 cohorts (dose 1, 2, 3, 4)

DRUG

Placebo

4 cohorts (dose 1, 2, 3, 4)

Trial Locations (1)

Unknown

Overland Park

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT01074372 - Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy Volunteers | Biotech Hunter | Biotech Hunter